Free Trial

Biofrontera (BFRI) SEC Filings & 10K Form

Biofrontera logo
$0.72 +0.03 (+4.33%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$0.72 0.00 (-0.42%)
As of 05/2/2025 07:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Biofrontera SEC Filings

DateFilerForm TypeView
04/30/2025
3:15 PM
Biofrontera (Filer)
Biofrontera Inc. (Filer)
Form DEF 14A
03/21/2025
7:15 AM
Biofrontera (Filer)
Biofrontera Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2025
4:18 PM
Biofrontera (Filer)
Biofrontera Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2025
10:29 AM
Biofrontera (Subject)
Biofrontera Inc. (Subject)
Rosalind Advisors, Inc. (Filed by)
Form SCHEDULE 13G/A
01/29/2025
6:58 PM
Biofrontera (Subject)
Biofrontera Inc. (Subject)
HIRSCHMAN ORIN (Filed by)
Form SCHEDULE 13G/A
01/28/2025
11:15 PM
Biofrontera (Filer)
Biofrontera Inc. (Filer)
Form EFFECT
01/21/2025
8:24 AM
Biofrontera (Filer)
Biofrontera Inc. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/20/2024
11:40 AM
Biofrontera (Subject)
Biofrontera Inc. (Subject)
DEUTSCHE BALATON AKTIENGESELLSCHAFT (Filed by)
Form SCHEDULE 13D/A
12/05/2024
7:56 AM
Biofrontera (Filer)
Biofrontera Inc. (Filer)
Form D
Notice of Exempt Offering of Securities 
11/27/2024
8:26 AM
Biofrontera (Filer)
Biofrontera Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2024
8:14 AM
Biofrontera (Filer)
Biofrontera Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
4:16 PM
Biofrontera (Filer)
Biofrontera Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/13/2024
4:20 PM
Biofrontera (Filer)
Biofrontera Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
1:12 PM
Biofrontera (Subject)
Biofrontera Inc. (Subject)
Saad Nabil (Filed by)
Form SC 13G/A
11/06/2024
9:48 AM
Biofrontera (Subject)
Biofrontera Inc. (Subject)
Rosalind Advisors, Inc. (Filed by)
Form SC 13G/A
11/01/2024
4:28 PM
Bigger Capital, LLC (Filed by)
Biofrontera (Subject)
Biofrontera Inc. (Subject)
Form SC 13G/A
10/31/2024
2:25 PM
Biofrontera (Filer)
Biofrontera Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2024
2:14 PM
Biofrontera (Subject)
Biofrontera Inc. (Subject)
Rosalind Advisors, Inc. (Filed by)
Form SC 13G/A
10/07/2024
7:45 AM
Biofrontera (Filer)
Biofrontera Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
8:46 AM
Biofrontera (Subject)
Biofrontera Inc. (Subject)
Saad Nabil (Filed by)
Form SC 13G
08/14/2024
3:49 PM
Biofrontera (Filer)
Biofrontera Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2024
6:52 PM
Biofrontera (Issuer)
Biofrontera Inc. (Issuer)
BORER JOHN J III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
6:52 PM
Biofrontera (Issuer)
Biofrontera Inc. (Issuer)
Luebbert Hermann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
6:52 PM
Biofrontera (Issuer)
Biofrontera Inc. (Issuer)
Hoffman Beth J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
6:52 PM
Biofrontera (Issuer)
Biofrontera Inc. (Issuer)
Leffler Eugene Frederick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
6:52 PM
Biofrontera (Issuer)
Biofrontera Inc. (Issuer)
Lanckriet Heikki (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
6:52 PM
Biofrontera (Issuer)
Biofrontera Inc. (Issuer)
Weber Kevin Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
7:34 AM
Biofrontera (Filer)
Biofrontera Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
3:30 PM
Biofrontera (Filer)
Biofrontera Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2024
2:21 PM
Biofrontera (Subject)
Biofrontera Inc. (Subject)
Rosalind Advisors, Inc. (Filed by)
Form SC 13G/A
05/22/2024
3:45 PM
Biofrontera (Issuer)
Biofrontera Inc. (Issuer)
Luebbert Hermann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
3:30 PM
Biofrontera (Filer)
Biofrontera Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
4:20 PM
Biofrontera (Filer)
Biofrontera Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
3:16 PM
Biofrontera (Filer)
Biofrontera Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
11:15 PM
Biofrontera (Filer)
Biofrontera Inc. (Filer)
Form EFFECT
05/07/2024
10:43 AM
Biofrontera (Subject)
Biofrontera Inc. (Subject)
Hewlett Fund LP (Filed by)
Form SC 13G
05/03/2024
8:15 AM
Biofrontera (Filer)
Biofrontera Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BFRI) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners